ANG Lifesciences India Limited (BOM:540694)

India flag India · Delayed Price · Currency is INR
23.00
-0.40 (-1.71%)
At close: Mar 9, 2026
-32.47%
Market Cap 300.34M
Revenue (ttm) 862.13M
Net Income (ttm) -117.64M
Shares Out 13.06M
EPS (ttm) -9.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 707
Average Volume 3,533
Open 23.40
Previous Close 23.40
Day's Range 23.00 - 24.89
52-Week Range 21.03 - 39.70
Beta -0.25
RSI 40.37
Earnings Date Feb 14, 2026

About ANG Lifesciences India

ANG Lifesciences India Limited engages in manufacturing and sale of finished pharmaceutical formulations in India and internationally. Its product portfolio comprises therapeutics categories, such as antibiotics, antiviral, antimalarial, antiulcer, carbapenem, corticosteroid, penicillin, and beta lactamase inhibitor. The company offers its finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials, liquid injection vials, ampoules, PFS, hard gelatin capsules, soft gelatin capsules, dry syrups, liquid syrups and ... [Read more]

Industry Pharmaceutical Preparations
Founded 2006
Employees 412
Stock Exchange Bombay Stock Exchange
Ticker Symbol 540694
Full Company Profile

Financial Performance

In fiscal year 2025, ANG Lifesciences India's revenue was 928.47 million, a decrease of -36.45% compared to the previous year's 1.46 billion. Losses were -124.13 million, 22.4% more than in 2024.

Financial Statements

News

There is no news available yet.